Harris, Jeffrey R |
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy |
|
|
| Completed | 2 | 190 | Canada, US | SUVN-G3031, Samelisant, Placebo | Suven Life Sciences Limited | Narcolepsy | 06/23 | 06/23 | | |
NCT05354115: Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. |
|
|
| Completed | N/A | 676 | US | Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel | Abbott Rapid Dx | COVID-19, Influenza A, Influenza Type B | 08/22 | 08/22 | | |
NCT05439551: Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study) |
|
|
| Completed | N/A | 215 | US, RoW | MeMed BV® | MeMed Diagnostics Ltd. | Acute Infection | 11/22 | 09/23 | | |
NCT03930420: Training LHDs to Disseminate Evidence-Based Interventions to Small Worksites |
|
|
| Terminated | N/A | 21 | US | Connect to Wellness | University of Washington, National Association of Chronic Disease Directors, National Cancer Institute (NCI) | Health Behavior | 03/24 | 03/24 | | |
Parsons, Samantha |
NCT03206801: Urine CXCL10 Monitoring Trial in Kidney Transplant |
|
|
| Active, not recruiting | 2/3 | 420 | Canada, RoW | Kidney transplant biopsy, Protocol biopsy | University of Manitoba, Canadian Institutes of Health Research (CIHR), Canadian National Transplant Research Program | Kidney Transplant; Complications, Rejection of Renal Transplant | 06/24 | 09/25 | | |
NCT05354115: Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. |
|
|
| Completed | N/A | 676 | US | Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel | Abbott Rapid Dx | COVID-19, Influenza A, Influenza Type B | 08/22 | 08/22 | | |
CARSK, NCT03674307: Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates |
|
|
| Recruiting | N/A | 3306 | Europe, Canada, US | No screening, Regular Screening | University of British Columbia, University of Sydney | Cardiovascular Diseases, End Stage Renal Disease, Kidney Transplantation, Dialysis Related Complication | 12/25 | 12/25 | | |